Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.25    -0.025 (-0.58%)
Bid:
4.35
Ask:
4.40
Spread: 0.05 (1.149%)
Market Cap: £203.98m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Directorate Change

31 Jul 2017 07:00

RNS Number : 5385M
Seeing Machines Limited
31 July 2017
 

Seeing Machines Limited

("Seeing Machines" or "the Company")

 

Directorate Change

 

31 July 2017

 

Seeing Machines (AIM: SEE), an industry leader in computer vision based technologies which enable machines to see, understand and assist people, announces that Peter Housden has tendered his resignation as Non-executive Director to allow him to spend more time on other commitments. He will step down from the Board with immediate effect.

 

Seeing Machines Executive Chairman, Ken Kroeger commented: "On behalf of the Board, we would like to acknowledge the contribution of Peter Housden to the Company as a director over the past 16 months. His experience and support has been valuable in that time and we wish him all the best in his future endeavours."

 

Enquiries:

 

Seeing Machines Limited

www.seeingmachines.com / +61 2 6103 4700

 

 

Mike McAuliffe, CEO

Mike.McAuliffe@seeingmachines.com

Media enquiries

 

Sophie.Nicoll@seeingmachines.com

finnCap Ltd

 

Ed Frisby / Emily Watts, Corporate Finance

+44 20 7220 0500

Tim Redfern / Richard Chambers, Corporate Broking

 

 

 

Canaccord Genuity Limited

 

 

 

Simon Bridges

+44 20 7423 8000

Richard Andrews

Alexander Napier

 

 

 

 

 

 

 

About Seeing Machines

 

Seeing Machines, (AIM: SEE) is an industry leader in computer vision based technologies which enable machines to see, understand and assist people. With more than 17 years of deep domain experience, Seeing Machines deploys its proprietary computer vision platform to deliver precision tracking and analysis of heads, faces and eyes. A primary application today is Driver Monitoring Systems (DMS) to detect and manage drowsiness, distraction and other cognitive states which is key to the safe adoption of Automotive ADAS and Autonomous Driving as well as our pioneering Guardian Fleet safety solution. A further application is real-time delivery of precision eye tracking in real world conditions, such as normalizing for all light conditions, required for next generation displays and human machine interfaces. The company delivers its Machine Learning Vision platform in a range of solutions from Embedded software to Fovio processors to Guardian Fleet products, delivering its roadmap of human sensing and understanding. Guardian combines an in-cabin safety intervention system with cloud telematics monitoring & analytics services, which prevents accidents and saves costs and lives. Seeing Machines' technology has been adopted by global industry leaders across the market spectrum. Seeing Machines is headquartered in Canberra, Australia and currently has offices and people in Melbourne, Tucson, Silicon Valley, Detroit and the UK.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAKMGFNKMGGNZG
Date   Source Headline
13th Jun 20197:00 amRNSFleet Momentum in New Zealand
10th Jun 20197:00 amRNSSelf-driving car company signs Guardian BdMS deal
7th Jun 201911:49 amRNSHolding(s) in Company
6th Jun 201912:53 pmRNSHolding(s) in Company
5th Jun 20191:03 pmRNSSenior Leadership Transition
16th May 20197:00 amRNSFleet Update
30th Apr 20192:58 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirectorate Change
25th Apr 201910:18 amRNSHolding(s) in Company
23rd Apr 20198:34 amRNSResult of GM, Offer and Total Voting Rights
10th Apr 20197:00 amRNSAutomotive deal with Joyson for US OEM
5th Apr 20197:00 amRNSSeeing Machines partners with Australian insurer
2nd Apr 201912:01 pmRNSIssue of Equity and Total Voting Rights
25th Mar 20192:00 pmRNSPosting of Offer Documents & Notice of GM
22nd Mar 20197:00 amRNSSubscription by Directors & Senior Management
20th Mar 201911:35 amRNSConditional Placing & Subscription to raise £27.5m
20th Mar 201911:29 amRNSHalf-year Report to 31 December 2018
8th Mar 20197:00 amRNSEye tracking technology trial with Toll
22nd Feb 20198:30 amRNSEU mandates safety technology for vehicles
19th Feb 20197:00 amRNSSixth Automotive OEM Design Win
16th Jan 20197:00 amRNSHalf year trading update
14th Jan 20197:00 amRNSCadillac Super Cruise 2019 Technology of the Year
13th Dec 20187:00 amRNSBoard Changes
12th Dec 20187:00 amRNSCollaboration with L3 to deliver eye tracking
6th Dec 20182:33 pmRNSIssue of Shares and Total Voting Rights
3rd Dec 20187:00 amRNSLuke Oxenham appointed Chief Financial Officer
26th Nov 20187:00 amRNSAviation division signs deal with Air Force
23rd Nov 20187:00 amRNSChief Financial Officer
16th Nov 20187:00 amRNSAppoints Paul McGlone to head Fleet division
14th Nov 20187:00 amRNSAGM Statement
14th Nov 20187:00 amRNSResult of AGM
22nd Oct 201810:27 amRNSNotice of AGM
17th Oct 20187:00 amRNSSeeing Machines appoints Ryan Murphy as COO
28th Sep 201811:05 amRNSIssue of Shares
19th Sep 20187:00 amRNSYear end results
11th Sep 20187:00 amRNSSeeing Machines launches Guardian BdMS
4th Sep 20182:06 pmRNSSecond Price Monitoring Extn
4th Sep 20182:00 pmRNSPrice Monitoring Extension
4th Sep 201811:05 amRNSSecond Price Monitoring Extn
4th Sep 201811:00 amRNSPrice Monitoring Extension
4th Sep 201810:19 amRNSSeeing Machines Limited Fleet Business Unit Update
29th Aug 20187:00 amRNSGuardian DMS covers more than 1 billion km
23rd Aug 201812:02 pmRNSTransfer of Ordinary Shares
16th Aug 201811:09 amRNSHolding(s) in Company
15th Aug 20189:41 amRNSIssue of Shares for Vested Performance Rights
9th Aug 20187:00 amRNSSeeing Machines leads pilot training collaboration
3rd Aug 20187:00 amRNSYear end trading update
27th Jul 20187:00 amRNSOEM Design Award
16th Jul 20187:00 amRNSBoard changes
5th Jul 20187:00 amRNSUS Fleet (Guardian) Contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.